Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIX NASDAQ:IVF NASDAQ:SSKN NASDAQ:VBIO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$0.39$0.38$0.20▼$2.64$2.66M-1.441.94 million shs79,160 shsIVFINVO Fertility$1.48$1.83$1.27▼$183.60$2.65M2.33797,173 shs44,432 shsSSKNStrata Skin Sciences$0.12$0.15$0.11▼$3.86$712K-0.06249,486 shs10,737 shsVBIOValion Bio, Inc. Common Stock$0.57$0.95$0.52▼$5.60$1.81M1.79430,539 shs414,994 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical0.00%-5.95%+18.65%-13.33%-70.34%IVFINVO Fertility0.00%-6.92%-7.21%-63.00%-99.06%SSKNStrata Skin Sciences0.00%-19.28%-0.82%-56.00%-94.65%VBIOValion Bio, Inc. Common Stock0.00%-25.53%-35.68%-43.40%-84.74%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$0.39$0.38$0.20▼$2.64$2.66M-1.441.94 million shs79,160 shsIVFINVO Fertility$1.48$1.83$1.27▼$183.60$2.65M2.33797,173 shs44,432 shsSSKNStrata Skin Sciences$0.12$0.15$0.11▼$3.86$712K-0.06249,486 shs10,737 shsVBIOValion Bio, Inc. Common Stock$0.57$0.95$0.52▼$5.60$1.81M1.79430,539 shs414,994 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical0.00%-5.95%+18.65%-13.33%-70.34%IVFINVO Fertility0.00%-6.92%-7.21%-63.00%-99.06%SSKNStrata Skin Sciences0.00%-19.28%-0.82%-56.00%-94.65%VBIOValion Bio, Inc. Common Stock0.00%-25.53%-35.68%-43.40%-84.74%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 2.00Hold$2.00418.67% UpsideIVFINVO Fertility 2.50Moderate Buy$20.001,251.35% UpsideSSKNStrata Skin Sciences 1.00SellN/AN/AVBIOValion Bio, Inc. Common Stock 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest SSKN, AMIX, VBIO, and IVF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)6/2/2026AMIXAutonomix Medical Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/18/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)5/6/2026IVFINVO Fertility Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)5/4/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)4/20/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/20/2026VBIOValion Bio, Inc. Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 6/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$0.85 per shareN/AIVFINVO Fertility$6.84M0.39N/AN/A$3.46 per share0.43SSKNStrata Skin Sciences$30.98M0.02N/AN/A$1.19 per share0.10VBIOValion Bio, Inc. Common Stock$780K2.32N/AN/A$6.65 per share0.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$16.72M-$3.55N/AN/AN/AN/A-239.36%-192.46%8/12/2026 (Estimated)IVFINVO Fertility-$25.13M-$3,151.46N/AN/AN/A-367.34%N/A-23.68%N/ASSKNStrata Skin Sciences-$10.09M-$1.41N/AN/AN/A-35.64%-476.73%-33.49%8/19/2026 (Estimated)VBIOValion Bio, Inc. Common Stock-$8.88M-$6.68N/AN/AN/AN/A-138.10%-63.67%N/ALatest SSKN, AMIX, VBIO, and IVF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/2/2026Q4 2025IVFINVO FertilityN/A$472.78N/A$472.78N/A$1.60 million5/14/2026Q1 2026VBIOValion Bio, Inc. Common StockN/A-$2.23N/A-$2.23N/AN/A3/30/2026Q4 2025VBIOValion Bio, Inc. Common Stock-$408.00-$1.0310+$406.9690-$1.35$0.46 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/ASSKNStrata Skin SciencesN/AN/AN/AN/AN/AVBIOValion Bio, Inc. Common StockN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A4.454.45IVFINVO Fertility0.150.270.25SSKNStrata Skin Sciences10.220.950.75VBIOValion Bio, Inc. Common Stock0.623.313.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%IVFINVO Fertility12.02%SSKNStrata Skin Sciences32.43%VBIOValion Bio, Inc. Common Stock4.25%Insider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical6.20%IVFINVO Fertility0.72%SSKNStrata Skin Sciences40.92%VBIOValion Bio, Inc. Common Stock2.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical16.91 million6.48 millionN/AIVFINVO Fertility101.79 million1.77 millionNo DataSSKNStrata Skin Sciences1205.89 million3.48 millionNot OptionableVBIOValion Bio, Inc. Common Stock103.20 million3.13 millionNot OptionableSSKN, AMIX, VBIO, and IVF HeadlinesRecent News About These CompaniesVALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROMEMay 19, 2026 | prnewswire.comValion Bio, Inc.: Valion Bio Reports First Quarter 2026 Financial ResultsMay 15, 2026 | finanznachrichten.deValion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling workMay 14, 2026 | seekingalpha.comValion Bio Inc. (VBIO) Q1 2026 Earnings Call Prepared Remarks TranscriptMay 14, 2026 | seekingalpha.comValion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ PlatformMay 14, 2026 | prnewswire.comVALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSMay 14, 2026 | prnewswire.comValion Bio to Report First Quarter 2026 Financial Results on May 14, 2026May 11, 2026 | prnewswire.comValion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™May 6, 2026 | prnewswire.comVALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSIONMay 5, 2026 | prnewswire.comTivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple ...April 23, 2026 | finance.yahoo.comTivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream ModelApril 23, 2026 | prnewswire.comSheryle Bolton Purchases 10,000 Shares of Tivic Health Systems (NASDAQ:TIVC) StockApril 21, 2026 | insidertrades.comTivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7thApril 15, 2026 | prnewswire.comTivic Health Systems, Inc.April 3, 2026 | edition.cnn.comTivic Health Systems (NASDAQ:TIVC) Director Christina Rizopoulos Valauri Acquires 19,000 SharesApril 3, 2026 | insidertrades.comTivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of EntolimodMarch 31, 2026 | accessnewswire.comAHead to Head Analysis: Tivic Health Systems (NASDAQ:TIVC) versus American Well (NYSE:AMWL)March 29, 2026 | defenseworld.netDTivic Health Systems: Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual ConferenceMarch 27, 2026 | finanznachrichten.deTivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual ConferenceMarch 27, 2026 | accessnewswire.comATivic Health Systems: Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation SyndromeMarch 26, 2026 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSSKN, AMIX, VBIO, and IVF Company DescriptionsAutonomix Medical NASDAQ:AMIX$0.39 0.00 (0.00%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$0.38 -0.01 (-1.45%) As of 06/12/2026 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.INVO Fertility NASDAQ:IVF$1.48 0.00 (0.00%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$1.44 -0.04 (-2.97%) As of 06/12/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.Strata Skin Sciences NASDAQ:SSKN$0.12 0.00 (0.00%) As of 06/12/2026 03:06 PM EasternSTRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.Valion Bio, Inc. Common Stock NASDAQ:VBIO$0.57 0.00 (0.00%) As of 06/12/2026 04:00 PM EasternTivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? Alphabet's Most Overlooked Division Just Had a Big Week Robinhood Wants a Bigger Role in IPOs—Here's Why It Matters Viasat's Orbiting Profits: Space Force Jackpot? What to Expect From Q2 Earnings as Tech Strength Broadens ERock IPO: A $1.3B Power Play Solution TJX: Retail’s Apex Predator Feasts on Inflation Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
